ANNA OWCZARSKI: Open Payments
NPI 1154718856 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 40 payments from 12 companies in 2025. Trend: 2023 $1,549 · 2024 $1,008 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $294 |
| ABBVIE INC. | 5 | $196 |
| Novo Nordisk Inc | 7 | $156 |
| Lilly USA, LLC | 9 | $154 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $20 |
Products named: REPATHA, QULIPTA, Ozempic, MOUNJARO, JARDIANCE, TRELEGY ELLIPTA, Rybelsus, KISUNLA.
Industry payments across MI — which companies pay providers there.
